MedPath

Development of software that predicts the response of chemotherapy in colorectal and head and neck cancers through artificial intelligence

Not Applicable
Conditions
Health Condition 1: C189- Malignant neoplasm of colon, unspecifiedHealth Condition 2: C14- Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx
Registration Number
CTRI/2022/10/046397
Lead Sponsor
BIRAC
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Persons above 18 years of age, diagnosed with HNSCC or CRC, any grade, any stage, chemo-naïve or previously treated and unresponsive to treatment, capable of giving consent

Exclusion Criteria

Persons without HNSCC or CRC or those incapable of giving consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath